3Mitra B, Panja M. High sensitive C-reactive protein:a novel biochemical markers and its role in coronary artery disease [ J ]. J Assoc Physicians India,2005 ;53 (6) :25-32.
2TANIGUCHI H,MOMIYAMA Y,OHMORI R,et al.Associations of plasma C-reactive protein levels with the presence and extent of coronary stenosis in patients with stable coronary artery disease[J].Atherosclerosis,2005,178(1):173-177.
3PERSSON GR,PETTERSSON T,OHLSSON O,et al.High-sensitivity serum C-reactive protein levels in subjects with or without myocardial infarction or periodontitis[J].J Clin Periodontol,2005,32(3):219-224.
4ABOU DIWAN CH,OGHLAKIAN GO,et al.The role of high sensitivity C-reactive protein in coronary artery disease risk prediction:a review[J].J Med Liban,2004,52(1):39-47.
5KULLER LH,TRACY RP,SHATEN J,et al.Relation of C-reactive protein and coronary heart disease in the MRFIT nested case control study[J].Am J Epidemiol,1996,144(6):537-547.
6YAZIC1 M,DEMIRCAN S,DURNA K,et al.Lipoprotein(a) levels in patients with unstable angina and their relationship with atherothrombosis and myocardial damage[J].Int J Clin Pract,2005,59(2):150-155.
8SEED M,AYRES KL,HUMPHRIES SE,et al.Lipoorotein(a)as a predictor of myocardial infaction in middle-aged men[J].Am J Med,2001,110(1):22-27.
9Berg K. A new serum type system in men - the lipoprotein system[ J ]. Acta pathol Microbiol Scand, 1963,59 :369 - 382.
10Murai A,Miyahara T, Fujimoto N, et al. Lp (a) Lipoprotein as a risk factor for coronary heart disease and cerebral infarction[J]. Atherosclerosis, 1986, 59(2) :199 - 204.
3Lemenev VL,Kungurtsev EV.Clinieal and ultrasound diag-nostics of a- cute venous thrombosis[J].Khirurgiia(Mosk) ,2008, (5) : 11-16.
4Ricky Autar.Nursing assessment of clients at risk of deep vein throm- bosis(DVT): the Autar DVT scale[J]. Journal of Advanced Nursing, 1996,23(4) :645-652.
6HOFFE MEISTER HM, EHLERS R, BUTFCHER K, et at. Comparison of C-reactive proteinand terminal complement com- plex in patients with unstable anginapectoris versus stable angina pectoris[J]. Am J Cardiol, 2002, 89: 909-912.
7RIDKER PM. High -sensitivihy C-reactive protein :potential ad- junctfor global risk assessmentin the primary primary prevention of cardiovasculardisease[J]. Circulation, 2001, 103: 1813-1818.
8ZHAO Q. Inflammation, autoimmunit y and atherosclerosis[J]. Discov Med, 2009, 8(40): 7-12.
9HUA Y, XUE J ,SUN F, et al. Aspirin inhibits MMP-2 and MMP-9 expressions and activities through upregulation of PPA- R c: / 3' and TIMP gene expressions in ox-LDL-stimulated macrophages derived from human monocytes [J]. Pharmacology, 2009, 83(1): 18-25.
10KU BEN SKII GE, ARDASHEV VN, CHERNOV SA, et ab The cell immunity parameters in patients with acute coronary syn- drome[J]. Klin Med (Mosk), 2006, 84(2): 32-35.
